Evidence map›Paper›PMID 41087732›Full record

ArticleEuropean journal of human genetics : EJHG2026

Patient passports for rare diseases: results of a pilot study.

Jo Balfour, Vaila Morrison, Lydia Seed, Joseph Clymer, Emma Warnants, Abigail Lampkin, Sarah M Leiter, Gemma Chandratillake

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. New year, new insights in genomic medicine.European journal of human genetics : EJHG · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jo BalfourCambridge Rare Disease Network, Cambridge, UK.
Vaila MorrisonCambridge Rare Disease Network, Cambridge, UK.
Lydia SeedDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Joseph ClymerGeorge Elliot Hospital, Coventry, UK.
Emma WarnantsCostello Medical, London, UK.
Abigail LampkinCostello Medical, London, UK.
Sarah M Leiter *Cambridge University Hospitals, Cambridge, UK. sml45@cam.ac.uk.ORCID 0000-0001-8321-3260
Gemma Chandratillake *NHS East Genomics, Cambridge, UK. gemma.chandratillake@nhs.net.ORCID 0000-0001-5917-7642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For individuals with rare diseases, complex needs requiring multidisciplinary management can cause disjointed healthcare and challenges communicating with healthcare professionals (HCPs). 'Patient passports' support communication and healthcare coordination by sharing healthcare information with HCPs, reducing burden on patients/caregivers. Currently, no widely adopted passport addresses the multifaceted needs of patients with rare diseases. This pilot study was a service evaluation of a rare-disease-specific patient passport, co-designed with patients and HCPs. Patients/caregivers completed surveys before ('pre-passport') and after ('post-passport') using the passport. HCPs were surveyed on their perception of the passport. Of 157 'pre-passport' survey respondents, 96.2% spent considerable time explaining medical needs to new care teams; 65.6% found communicating care needs challenging. Nearly all respondents (99.4%) believed a document presenting relevant healthcare information would be helpful. Among 55 'post-passport' survey respondents, 85.1% used the passport during care interactions; 72.2% found it eased communication with unfamiliar teams, and 64.2% felt more confident communicating their needs. Over half (53.8%) felt the passport helped access needed care, 67.9% found it more useful than existing tools, and 75.9% were highly likely to recommend it to peers. All 31 HCP respondents listed perceived benefits, including improved HCP-patient/caregiver communication; some noted a preference for formal endorsement. By alleviating patient/caregiver-HCP communication challenges, this rare-disease-specific patient passport can enhance healthcare coordination and patient experiences. Participants' use of the passport during interactions with care teams and likelihood of recommendation to peers support its widespread integration. Further work to assess usability across healthcare settings and to gain formal endorsement is warranted.

Indexed as

Rare DiseasesAdultFemaleHealth PersonnelHumansMaleMiddle AgedPilot ProjectsSurveys and Questionnaires

Identifiers

PMID41087732
PMCPMC12816684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.